BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 26457987)

  • 1. CCL18 from tumor-cells promotes epithelial ovarian cancer metastasis via mTOR signaling pathway.
    Wang Q; Tang Y; Yu H; Yin Q; Li M; Shi L; Zhang W; Li D; Li L
    Mol Carcinog; 2016 Nov; 55(11):1688-1699. PubMed ID: 26457987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study of growth, invasion and metastasis on ovarian epithelial cancer cell line with CCL18 over-expression by mediated in vitro].
    Zhang W; Yang YZ; Li L; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 2013 Jul; 48(7):528-31. PubMed ID: 24284226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokine (CC motif) ligand 18 upregulates Slug expression to promote stem-cell like features by activating the mammalian target of rapamycin pathway in oral squamous cell carcinoma.
    Wang H; Liang X; Li M; Tao X; Tai S; Fan Z; Wang Z; Cheng B; Xia J
    Cancer Sci; 2017 Aug; 108(8):1584-1593. PubMed ID: 28574664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CC Chemokine Ligand 18 Promotes Cell Proliferation and Metastasis of Urothelial Carcinoma via Activating PI3K/mTOR Signaling in Patient with Renal Transplantation.
    Bo S; Donghao S; Guangqi K; Ye T
    Urol Int; 2018; 101(4):450-458. PubMed ID: 30189425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-206 inhibits epithelial ovarian cancer cells growth and invasion via blocking c-Met/AKT/mTOR signaling pathway.
    Dai C; Xie Y; Zhuang X; Yuan Z
    Biomed Pharmacother; 2018 Aug; 104():763-770. PubMed ID: 29807226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sanguinarine inhibits epithelial ovarian cancer development via regulating long non-coding RNA CASC2-EIF4A3 axis and/or inhibiting NF-κB signaling or PI3K/AKT/mTOR pathway.
    Zhang S; Leng T; Zhang Q; Zhao Q; Nie X; Yang L
    Biomed Pharmacother; 2018 Jun; 102():302-308. PubMed ID: 29571014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nir1 promotes invasion of breast cancer cells by binding to chemokine (C-C motif) ligand 18 through the PI3K/Akt/GSK3β/Snail signalling pathway.
    Zhang B; Yin C; Li H; Shi L; Liu N; Sun Y; Lu S; Liu Y; Sun L; Li X; Chen W; Qi Y
    Eur J Cancer; 2013 Dec; 49(18):3900-13. PubMed ID: 24001613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCL18-NIR1 promotes oral cancer cell growth and metastasis by activating the JAK2/STAT3 signaling pathway.
    Jiang X; Huang Z; Sun X; Zheng X; Liu J; Shen J; Jia B; Luo H; Mai Z; Chen G; Zhao J
    BMC Cancer; 2020 Jul; 20(1):632. PubMed ID: 32641093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The PI3K/AKT/mTOR pathway is a potential predictor of distinct invasive and migratory capacities in human ovarian cancer cell lines.
    Bai H; Li H; Li W; Gui T; Yang J; Cao D; Shen K
    Oncotarget; 2015 Sep; 6(28):25520-32. PubMed ID: 26267321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCL18 from ascites promotes ovarian cancer cell migration through proline-rich tyrosine kinase 2 signaling.
    Lane D; Matte I; Laplante C; Garde-Granger P; Carignan A; Bessette P; Rancourt C; Piché A
    Mol Cancer; 2016 Sep; 15(1):58. PubMed ID: 27613122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCL18 promotes the invasion and metastasis of breast cancer through Annexin A2.
    Zhao C; Zheng S; Yan Z; Deng Z; Wang R; Zhang B
    Oncol Rep; 2020 Feb; 43(2):571-580. PubMed ID: 31894281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCL18 promotes the metastasis of squamous cell carcinoma of the head and neck through MTDH-NF-κB signalling pathway.
    Qin Y; Wang J; Zhu G; Li G; Tan H; Chen C; Pi L; She L; Chen X; Wei M; Li Z; Liu Z; Huang D; Liu Y; Zhang X
    J Cell Mol Med; 2019 Apr; 23(4):2689-2701. PubMed ID: 30768878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DHA inhibits invasion and metastasis in NSCLC cells by interfering with CCL18/STAT3 signaling pathway.
    Luo HQ; Huang YM; Li J; Tang XD; Chen R; Wang Y; Ren J; Dai QQ; Lan LB; Chen JY; Li XY
    Clin Exp Med; 2023 Oct; 23(6):2311-2320. PubMed ID: 36217054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage ERα promoted invasion of endometrial cancer cell by mTOR/KIF5B-mediated epithelial to mesenchymal transition.
    Jing X; Peng J; Dou Y; Sun J; Ma C; Wang Q; Zhang L; Luo X; Kong B; Zhang Y; Wang L; Qu X
    Immunol Cell Biol; 2019 Jul; 97(6):563-576. PubMed ID: 30779215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue factor-factor VIIa complex induces epithelial ovarian cancer cell invasion and metastasis through a monocytes-dependent mechanism.
    Ma Z; Zhang T; Wang R; Cheng Z; Xu H; Li W; Wang Y; Wang X
    Int J Gynecol Cancer; 2011 May; 21(4):616-24. PubMed ID: 21543928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LPA receptor 1 mediates LPA-induced ovarian cancer metastasis: an in vitro and in vivo study.
    Yu X; Zhang Y; Chen H
    BMC Cancer; 2016 Nov; 16(1):846. PubMed ID: 27809800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CC chemokine ligand 18(CCL18) promotes migration and invasion of lung cancer cells by binding to Nir1 through Nir1-ELMO1/DOC180 signaling pathway.
    Shi L; Zhang B; Sun X; Zhang X; Lv S; Li H; Wang X; Zhao C; Zhang H; Xie X; Wang Y; Zhang P
    Mol Carcinog; 2016 Dec; 55(12):2051-2062. PubMed ID: 26756176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCL18-induced HOTAIR upregulation promotes malignant progression in esophageal squamous cell carcinoma through the miR-130a-5p-ZEB1 axis.
    Wang W; Wu D; He X; Hu X; Hu C; Shen Z; Lin J; Pan Z; He Z; Lin H; Wang M
    Cancer Lett; 2019 Sep; 460():18-28. PubMed ID: 31207321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA RP11-552M11.4 promotes cells proliferation, migration and invasion by targeting BRCA2 in ovarian cancer.
    Huang K; Geng J; Wang J
    Cancer Sci; 2018 May; 109(5):1428-1446. PubMed ID: 29478268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PDCD6 is an independent predictor of progression free survival in epithelial ovarian cancer.
    Su D; Xu H; Feng J; Gao Y; Gu L; Ying L; Katsaros D; Yu H; Xu S; Qi M
    J Transl Med; 2012 Feb; 10():31. PubMed ID: 22369209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.